Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120032) titled 'The dose-response of alfentanil combined with remimazolam on bronchoscopy in elderly patients' on March 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhejiang Rongjun Hospital
Condition:
Bronchoscopy
Intervention:
Experimental Group:If the result is negative, it is considered a success, and the alfentanil dosage for the next patient is reduced by one level
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-10
Target Sample Size: Experimental Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpr...